Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido

Inclusion Criteria: Eligible women must: Be 20-70 years old and in generally good health Have undergone hysterectomy and removal of both ovaries at least 6 months prior to screening Be receiving a stable dose of estrogen replacement therapy for at least 3 months prior to screening with the intention of maintaining that regimen. Be, in her own judgment, in a stable monogamous sexual relationship that is perceived to be secure and communicative, for at least one year prior to study entry. Meet the criteria for having hypoactive sexual desire disorder. Exclusion Criteria: Eligible women must not: Have received androgen therapy at any time during the past 3 months (during the past 7 months if therapy was an investigational implantable product) Be experiencing any chronic or acute life stress relating to any major life change Be experiencing depression and/or receiving medication for such illness or disorder Have current severe skin problems (such as severe or cystic acne) or allergy to adhesives (like the ones in bandages) Have had a major illness, active gall bladder disease, or gynecological or breast surgery within the last 6 months Have a history of breast, endometrial, or other gynecological cancer any time before study participation or other cancer within the last 5 years Have diabetes, a history of cerebrovascular disease, thromboembolic disorders, heart attack, or angina at any time before study participation or thrombophlebitis within the last 5 years Have abnormal laboratory test results upon initial screening for this study Have previously participated in P&GP study 1999068 or 1999092 Have previously participated in a clinical trial within 30 days or received an investigation medication within 30 days.